REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,738 | -73.5% | 12,287 | -68.4% | 0.01% | -74.1% |
| Q1 2023 | $6,553 | +344.9% | 38,922 | +347.3% | 0.05% | +157.1% |
| Q4 2022 | $1,473 | -100.0% | 8,702 | -81.9% | 0.02% | -82.1% |
| Q3 2022 | $8,982,000 | +193.1% | 48,002 | +154.4% | 0.12% | +207.9% |
| Q2 2022 | $3,064,000 | -75.8% | 18,869 | -60.5% | 0.04% | -71.0% |
| Q4 2021 | $12,661,000 | -60.1% | 47,805 | -56.5% | 0.13% | -69.4% |
| Q3 2021 | $31,728,000 | +1400.1% | 109,790 | +909.1% | 0.43% | +1280.6% |
| Q1 2021 | $2,115,000 | +141.7% | 10,880 | +138.3% | 0.03% | +244.4% |
| Q4 2020 | $875,000 | +115.0% | 4,565 | +65.6% | 0.01% | +12.5% |
| Q3 2020 | $407,000 | -93.1% | 2,756 | -94.2% | 0.01% | -94.8% |
| Q2 2020 | $5,886,000 | +938.1% | 47,621 | +544.4% | 0.15% | +665.0% |
| Q3 2019 | $567,000 | +70.8% | 7,390 | +91.4% | 0.02% | +53.8% |
| Q2 2019 | $332,000 | – | 3,862 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |